Report: U.S. spinal market to reach $6.6B by 2021

A trend toward more minimally invasive surgeries will lead to modest growth in the U.S. spinal implant market over the next several years, and the sector will hit the $6.6 billion mark by 2021, Millennium Research Group said. Reimbursement challenges and the medical device tax will hamper broader growth, Millennium noted, but the sector will still expand, in part, as surgeons switch to minimally invasive surgeries for treatments. While the spinal fusion implant market is very mature, the nonfusion implant market is growing quickly, Millennium said, adding that NuVasive, Globus Medical and LDR Spine have all launched new cervical artificial discs in recent months. Item

Suggested Articles

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.

The FDA has given Grail a green light to conduct the interventional study, and it has begun enrolling participants through the company’s R&D partners.

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.